BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21856017)

  • 1. Agreement between physicians' and patients' ratings on the Montgomery-Åsberg Depression Rating Scale.
    Cunningham JL; Wernroth L; von Knorring L; Berglund L; Ekselius L
    J Affect Disord; 2011 Dec; 135(1-3):148-53. PubMed ID: 21856017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
    Fantino B; Moore N
    BMC Psychiatry; 2009 May; 9():26. PubMed ID: 19473506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice.
    Bondolfi G; Jermann F; Rouget BW; Gex-Fabry M; McQuillan A; Dupont-Willemin A; Aubry JM; Nguyen C
    J Affect Disord; 2010 Mar; 121(3):268-72. PubMed ID: 19660815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' perspectives on the use of the Montgomery-Asberg depression rating scale self-assessment version in primary care.
    Wikberg C; Pettersson A; Westman J; Björkelund C; Petersson EL
    Scand J Prim Health Care; 2016 Dec; 34(4):434-442. PubMed ID: 27804312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS).
    Svanborg P; Asberg M
    J Affect Disord; 2001 May; 64(2-3):203-16. PubMed ID: 11313087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
    Zimmerman M; Posternak MA; Chelminski I
    J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach.
    Duru G; Fantino B
    Curr Med Res Opin; 2008 May; 24(5):1329-35. PubMed ID: 18377706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale.
    Müller MJ; Szegedi A; Wetzel H; Benkert O
    J Affect Disord; 2000 Nov; 60(2):137-40. PubMed ID: 10967373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating the HAM-D into the MADRS and vice versa with equipercentile linking.
    Leucht S; Fennema H; Engel RR; Kaspers-Janssen M; Szegedi A
    J Affect Disord; 2018 Jan; 226():326-331. PubMed ID: 29031182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of depressive symptoms in patients with coronary artery disease using the Montgomery Åsberg Depression Rating Scale.
    Bunevicius A; Staniute M; Brozaitiene J; Pommer AM; Pop VJ; Montgomery SA; Bunevicius R
    Int Clin Psychopharmacol; 2012 Sep; 27(5):249-55. PubMed ID: 22869009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance on the conversion of the Chinese versions of the Quick Inventory of Depressive Symptomatology-Self-Report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression.
    Liu J; Xiang YT; Lei H; Wang Q; Wang G; Ungvari GS; Morris DW; Zhu XZ; Lai KY; Zhong BL; Wong SY; Zhang L; Zhang Q; Zou YC; Xiao L; Zhao Q; Li Y; Wu J; Zhang GF; Chiu HF
    J Affect Disord; 2014 Jan; 152-154():530-3. PubMed ID: 24144585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies.
    Leucht S; Fennema H; Engel RR; Kaspers-Janssen M; Lepping P; Szegedi A
    J Affect Disord; 2017 Mar; 210():287-293. PubMed ID: 28068617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing depression severity with a self-rated vs. rater-administered instrument in patients with epilepsy.
    Jamal-Omidi S; Collins C; Fulchiero E; Liu H; Colon-Zimmermann K; Fuentes-Casiano E; Tatsuoka C; Cassidy KA; Lhatoo S; Sajatovic M
    Epilepsy Behav; 2018 Aug; 85():52-57. PubMed ID: 29908384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).
    Müller MJ; Himmerich H; Kienzle B; Szegedi A
    J Affect Disord; 2003 Dec; 77(3):255-60. PubMed ID: 14612225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of the Montgomery-Åsberg Depression Rating Scale parent report among adolescent psychiatric outpatients.
    Torres Soler C; Olofsdotter S; Vadlin S; Ramklint M; Nilsson KW; Sonnby K
    Nord J Psychiatry; 2018 Apr; 72(3):184-190. PubMed ID: 29258381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features).
    Targum SD; Pendergrass JC; Lee S; Loebel A
    Int J Methods Psychiatr Res; 2018 Dec; 27(4):e1729. PubMed ID: 29943445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Validity and Factor Analysis of Montgomery-Asberg Depression Rating Scale in Parkinson Disease Population.
    Ketharanathan T; Hanwella R; Weerasundera R; de Silva VA
    J Geriatr Psychiatry Neurol; 2016 May; 29(3):115-9. PubMed ID: 26392481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    Graystone HJ; Garner MJ; Baldwin DS
    J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response.
    Johnson KM; Devine JM; Ho KF; Howard KA; Saretsky TL; Jamieson CA
    J Clin Psychiatry; 2016 Dec; 77(12):1681-1686. PubMed ID: 28086004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.